Products

EMARKETER delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
PRO+
New data sets, deeper insights, and flexible data visualizations.
Learn More
Reports
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Forecasts
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Charts
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Briefings
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About EMARKETER

Our goal is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Events
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Podcasts
Tune in to EMARKETER's daily, weekly, and monthly podcasts.
Learn More

Is the digital health SPAC frenzy dead?

The news: Rock Health’s Q3 2021 digital health funding report included a ton of data about digital health investments—we’re breaking down two key data findings: The simultaneous rise in mental health funding and slowdown of digital health SPAC deals.

The data: Digital health startup funding slowed down in Q3’21, hitting $6.7 billion from a high of $8.1 billion in Q2—but this year’s investments have already surpassed the collective $20 billion raised during 2020.

  • Mental health was the top-funded therapeutic area in Q3—telemental health startups scored $3.1 billion, with startups tackling substance use disorder like Quit Genius earning more dollars than ever.
  • And womens’ digital health startups saw a YoY funding boost: Startups in this category scored 2.3X more funding in Q3 than the same time last year.

What’s next? We predict investors will place their bets on more niche mental health areas—in particular, pediatric telemental health—through the rest of the year, simply due to the high demand of these services.

There’s a dire shortage of pediatric mental health professionals as kids’ US mental health declines during the pandemic—and there are a few digital health startups raising cash to address this gap in care.

  • For example, near the end of Q3 2021, investors poured $13 million into pediatric telemental health startups like DotCom Therapy, which is teaming up with in-school telehealth providers to make therapy services accessible for kids where they’re spending the most time: school.

Since there aren’t a ton of kids’ digital mental health startups, the handful that do exist are likely to nab attention from investors that want to stake their claim in this underdeveloped but high-demand space:

  • We could see startups like Centene-backed Hazel Health (which operates virtual clinics inside school nurse offices in over 40 US school districts) score another funding round, for instance.

Other new data: Q3 also saw a slowdown in digital health SPAC deals, likely due to increased regulatory scrutiny.

  • There were three completed SPAC mergers and one announced SPAC deal in Q3, compared with four completed SPACs and seven announced SPACs in Q2, per Rock Health.

How we got here: In August, the SEC drafted a report recommending more disclosure rules for SPACs amid an IPO frenzy.

  • The SEC took this action shortly after it began investigating SPAC deals like insurtech Clover Health’s on allegations that the company misled investors about critical aspects of its business prior to its SPAC transaction.

What’s next? A crackdown on SPAC deals could slow down the digital health SPAC frenzy, but the number of digital health SPAC deals likely won’t return to pre-pandemic levels.

  • For context, In 2019, there were fewer than 60 SPACs formed (including non-digital health companies), but there were nearly 300 SPACs formed by the end of Q1 2021, per Crunchbase.

While the rate of SPAC deals could decrease, digital health startups likely won’t quit going public via SPAC altogether anytime soon:

  • Namely, SPACs could help startups raise more capital than a VC funding round alone.
  • For example, Telehealth company Hims & Hers received $280 million as a result of its SPAC deal this year—far higher than any of its previous funding rounds.